title: Gemcitabine in models of acute and accelerated rejection.
authors.affiliation: Department of General and Thoracic Surgery, Justus Liebig University, Giessen, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Jung
authors.forename: S
authors.initials: S
authors.lastname: Wilker
authors.forename: E
authors.initials: E
authors.lastname: Maas
authors.forename: M D
authors.initials: MD
authors.lastname: Brendel
authors.forename: H
authors.initials: H
authors.lastname: Grimm
authors.forename: S
authors.initials: S
authors.lastname: Korom
mesh_terms: D000208:Acute Disease; D000818:Animals; D003602:Cytotoxicity, Immunologic; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013997:Time Factors; D014184:Transplantation, Homologous; D000093542:Gemcitabine
chemical_list: D007166:Immunosuppressive Agents; D003841:Deoxycytidine; D000093542:Gemcitabine